122
Views
47
CrossRef citations to date
0
Altmetric
Review

Serum, salivary and tissue proteomics for discovery of biomarkers for head and neck cancers

, , &
Pages 93-100 | Published online: 09 Jan 2014

References

  • Vlahou A, Schellhammer PF, Mendrinos S et al. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am. J. Pathol.158, 1491–1502 (2001).
  • Adam BL, Qu Y, Davis JW et al. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res.62, 3609–3614 (2002).
  • Petricoin EF, Ardekani AM, Hitt BA et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet359, 572–577 (2002).
  • Li J, Zhang Z, Rosenzweig J et al. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin. Chem.48, 1296–1304 (2002).
  • Wadsworth JT, Somers KD, Cazeres LH et al. Serum protein profiles to identify head and neck cancer. Clin. Cancer Res.10(5) 1625–1632 (2004).
  • Wadsworth JT, Somers KD, Stack BC Jr et al. Identification of patients with head and neck cancer using serum protein profiles. Arch. Otolaryngol. Head Neck Surg.130, 98–104 (2004).
  • Pusztai L, Gregory BW, Baggerly KA et al. Pharmacoproteomic analysis of pre- and post-chemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast cancer. Cancer100, 1814–1822 (2004).
  • Laronga C, Becker S, Watson P et al. SELDI-TOF Serum profiling for prognostic and diagnostic classification of breast cancers. Dis. Markers19, 229–238 (2004).
  • Sidransky D, Irizarry R, Califano JA et al. Serum protein MALDI profiling to distinguish upper aerodigestive tract cancer patients from control subjects. J. Natl Cancer Inst.95, 1711–1717 (2003).
  • Melle C, Ernst G, Schimmel B et al. Biomarker discovery and identification in laser microdissected head and neck squamous cell carcinoma with ProteinChip® technology, two-dimensional gel electrophoresis, tandem mass spectrometry, and immunohistochemistry. Mol. Cell. Proteomics2, 443–452 (2003).
  • Melle C, Ernst G, Schimmel B et al. A technical triade for proteomic identification and characterization of cancer biomarkers. Cancer Res.64, 4099–4104 (2004).
  • Gygi SP, Rist B, Griffin TJ et al. Proteome analysis of low-abundance proteins using multidimensional chromatography and isotope-coded affinity tags. J. Proteome Res.1, 47–54 (2002).
  • Shen Y, Tolic N, Zhao R et al. High-throughput proteomics using high-efficiency multiple-capillary liquid chromatography with on-line high-performance ESI FTICR mass spectrometry. Anal. Chem.73, 3011–3021 (2001).
  • Pisani P, Bray F, Parkin DM. Estimates of the worldwide prevalence of cancer for 25 sites in the adult population. Int. J. Cancer97, 72–81 (2002).
  • Warnakulasuriya S. Cancers of the oral cavity and pharynx. In: The Genetic Basis of Human Cancer, second edition. Vogelstein B, Kinzler KW (Eds), McGraw-Hill Co., NY, USA, 773–784 (2002).
  • Bedi GC, Westra WH, Gabrielson E et al. Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res.56, 2484–2487 (1996).
  • Smith RA, Cokkinides V, von Eschenbach AC et al. American Cancer Society Guidelines for the early detection of cancer. CA Cancer J. Clin.52, 8–22 (2002).
  • Kowalski LP, Medina JE. Nodal metastases. Otolaryngol. Clin. North Am.31, 621–637 (1998).
  • American Joint Committee on Cancer Staging, fifth edition. Lippincott Williams & Wilkins, PA, USA (1998).
  • Patel V, Leethanakul C, Gutkind JS. New approaches to the understanding of the molecular basis of oral cancer. Crit. Rev. Oral Biol. Med.12, 55–63 (2001).
  • Wiseman SM, Stoler DL, Anderson GR. The role of genomic instability in the pathogenesis of squamous cell carcinoma of the head and neck. Surg. Oncol. Clin. N. Am.13, 1–11 (2004).
  • Hu YC, Sidransky D, Ahrendt SA. Molecular detection approaches for smoking associated tumors. Oncogene21, 7289–7297 (2002).
  • Kulpa J, Stasik Z, Skolyszewski J et al. Predictive value of SCC-Ag, CYFRA 21-1 and selected acute phase proteins in radiotherapy of pharyngeal and laryngeal cancer. A preliminary report. Neoplasma51, 103–109 (2004).
  • Wright GL Jr. SELDI proteinchip MS: a platform for biomarker discovery and cancer diagnosis. Expert Rev. Mol. Diagn.2, 549–563 (2002).
  • Issaq HJ, Conrads TP, Prieto DA et al. SELDI-TOF MS for diagnostic proteomics. Anal. Chem.75, 148A–155A (2003).
  • von Eggeling F, Davies H, Lomas L et al. Tissue-specific microdissection coupled with ProteinChip* array technologies: applications in cancer research. BioTechniques29, 1066–1070 (2000).
  • Wu W, Tang X, Hu W et al. Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry. Clin. Exp. Metastasis19, 319–326 (2002).
  • Qu Y, Adam BL, Yasui Y et al. Boosted decision tree analysis of SELDI mass speactral serum profiles discriminates prostate cancer from non-cancer patients. Clin. Chem.48, 1835–1843 (2002).
  • Yasui Y, Pepe M, Thompson ML et al. A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection. Biostatistics4, 449–463 (2003).
  • White CN, Chan DW, Zhang Z. Bioinformatics strategies for proteomic profiling. Clin. Biochem.37, 636–641 (2004).
  • Baggerly KA, Morris JS, Coombes KR. Reproducibility of SELDI-TOF protein patterns in serum: comparing data sets from different experiments. Bioinformatics20, 777–785 (2004).
  • Petricoin EF, Fishman DA, Conrads TP et al. Lessons from Kitty Hawk: from feasibility to routine clinical use for the field of proteomic pattern diagnostics. Proteomics4, 2357–2360 (2004).
  • Diamandis EP. Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and limitations. Mol. Cell. Proteomics3, 367–378 (2004).
  • Mehta AI, Ross S, Lowenthal MS et al. Biomarker amplification by serum carrier protein binding. Dis. Markers19, 1–10 (2004).
  • Malik G, Ward MD, Grizzle WE et al. Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer. Clin. Cancer Res. (2004) (In Press).
  • Chen J, He QY, Yuen AP, Chiu JF. Proteomics of buccal squamous cell carcinoma: the involvement of multiple pathways in tumorigenesis. Proteomics4, 2465–2475 (2004).
  • He QY, Chen J, Kung HF et al. Identification of tumor-associated proteins in oral tongue squamous cell carcinoma by proteomics. Proteomics4, 271–278 (2004).
  • Emmert-Buck MR, Bonner RF, Smith PD et al. Laser capture microdissection. Science274, 998–1000 (1996).
  • Emmert-Buck MR, Strausberg RL, Krizman DB et al. Molecular profiling of clinical tissues specimens: feasibility and applications. J. Mol. Diagn.2, 60–66 (2000).
  • Leethanakul C, Patel V, Gillespie J et al. Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays. Oncogene19, 3220–3224 (2000).
  • Ornstein DK, Gillespie JW, Paweletz CP et al. Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines. Electrophoresis21, 2235–2242 (2000).
  • Zhou G, Li H, DeCamps D et al. 2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers. Mol. Cell. Proteomics1, 117–124 (2002).
  • Streckfus CF, Bigler LR. Saliva as a diagnostic fluid. Oral Dis.8, 69–76 (2002).
  • Humphrey SP, Williamson RT. A review of saliva: normal composition, flow and function. J. Prosthet. Dent.85, 162–169 (2001).
  • Ghafouri B, Tagesson C, Lindahl M. Mapping of proteins in human saliva using two-dimensional gel electrophoresis and peptide mass fingerprinting. Proteomics3, 1003–1015 (2003).
  • Vitorino R, Lobo MJ, Ferrer-Correira AJ et al. Identification of human whole saliva protein components using proteomics. Proteomics4, 1109–1115 (2004).
  • Franzmann EJ, Schroeder GL, Goodwin WJ et al. Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors. Int. J. Cancer106, 438–445 (2003).
  • St John MA, Li Y, Zhou X et al. Interleukin-6 and interleukin-8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg.130, 929–935 (2004).
  • Kulaksiz H, Rehberg E, Stremmel W, Cetin Y. Guanylin and functional coupling proteins in the human salivary glands and gland tumors: expression, cellular localization, and target membrane domains. Am. J. Pathol.161, 655–664 (2002).
  • Hafkamp HC, Manni JJ, Speel EJ. Role of human papillomavirus in the development of head and neck squamous cell carcinomas. Acta Otolaryngol.124, 520–526 (2004).

Website

  • National Cancer Institute, Division of Cancer Prevention www3.cancer.gov/prevention/cbrg/edrn (Viewed December 2004)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.